Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-FREE ECMO: Anticoagulation-free VV ECMO for ARDS
NCT04273607Phase 3Recruiting
- Start
- Sep 2022
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of heparin in extracorporeal membrane oxygenation complication. Started Sep 2022; status: recruiting.
02
Drugs
heparin
03
Conditions
extracorporeal membrane oxygenation complication
Beyond the preview
Go deeper on NCT04273607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04273607.